Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Development and characterization of a novel CD34 monoclonal antibody that identifies sheep hematopoietic stem/progenitor cells.

Porada CD, Harrison-Findik DD, Sanada C, Valiente V, Thain D, Simmons PJ, Almeida-Porada G, Zanjani ED.

Exp Hematol. 2008 Dec;36(12):1739-49. doi: 10.1016/j.exphem.2008.09.003.

2.

Cytokine-mobilized peripheral blood CD34+Thy-1+Lin- human hematopoietic stem cells as target cells for transplantation-based gene therapy.

Chen BP, Fraser C, Reading C, Murray L, Uchida N, Galy A, Sasaki D, Tricot G, Jagannath S, Barlogie B, et al.

Leukemia. 1995 Oct;9 Suppl 1:S17-25.

PMID:
7475307
3.

Characterization of monoclonal antibodies that recognize canine CD34.

McSweeney PA, Rouleau KA, Wallace PM, Bruno B, Andrews RG, Krizanac-Bengez L, Sandmaier BM, Storb R, Wayner E, Nash RA.

Blood. 1998 Mar 15;91(6):1977-86.

4.

Development of an anti-porcine CD34 monoclonal antibody that identifies hematopoietic stem cells.

Layton DS, Strom AD, O'Neil TE, Broadway MM, Stephenson GL, Morris KR, Muralitharan M, Sandrin MS, Ierino FL, Bean AG.

Exp Hematol. 2007 Jan;35(1):171-8.

PMID:
17198886
5.

The monoclonal antibody W7C5 defines a novel surface antigen on hematopoietic stem cells.

Giesert C, Almeida-Porada G, Scheffold A, Kanz L, Zanjani ED, Bühring HJ.

Ann N Y Acad Sci. 2001 Jun;938:175-83.

PMID:
11458505
6.

AC133, a novel marker for human hematopoietic stem and progenitor cells.

Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J, Buck DW.

Blood. 1997 Dec 15;90(12):5002-12.

7.

Identification of CD34+ subsets after glycoprotease selection: engraftment of CD34+Thy-1+Lin- stem cells in fetal sheep.

Sutherland DR, Yeo EL, Stewart AK, Nayar R, DiGiusto R, Zanjani E, Hoffman R, Murray LJ.

Exp Hematol. 1996 Jun;24(7):795-806.

PMID:
8647230
8.

Validation of a single-platform method for hematopoietic CD34+ stem cells enumeration according to accreditation procedure.

Massin F, Huili C, Decot V, Stoltz JF, Bensoussan D, Latger-Cannard V.

Biomed Mater Eng. 2015;25(1 Suppl):27-39. doi: 10.3233/BME-141226.

PMID:
25538053
9.

Primitive hematopoietic cells in murine bone marrow express the CD34 antigen.

Morel F, Szilvassy SJ, Travis M, Chen B, Galy A.

Blood. 1996 Nov 15;88(10):3774-84.

10.

Flow cytometry to estimate circulating hematopoietic progenitors for autologous transplantation: comparative analysis of different CD34 monoclonal antibodies.

Siena S, Bregni M, Brando B, Belli N, Lansdorp PM, Bonadonna G, Gianni M.

Haematologica. 1991 Jul-Aug;76(4):330-3.

PMID:
1724439
11.

Monoclonal antibody BB9 raised against bone marrow stromal cells identifies a cell-surface glycoprotein expressed by primitive human hemopoietic progenitors.

Ramshaw HS, Haylock D, Swart B, Gronthos S, Horsfall MJ, Niutta S, Simmons PJ.

Exp Hematol. 2001 Aug;29(8):981-92.

PMID:
11495704
12.

Who is hematopoietic stem cell: CD34+ or CD34-?

Pei X.

Int J Hematol. 1999 Dec;70(4):213-5. Review.

PMID:
10643145
13.

Effect of anti-CD52 antibody alemtuzumab on ex-vivo culture of umbilical cord blood stem cells.

Lim CK, Sun L, Feng Q, Law P, Chua WT, Lim SN, Hwang WY.

J Hematol Oncol. 2008 Oct 23;1:19. doi: 10.1186/1756-8722-1-19.

14.

Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution.

Michallet M, Philip T, Philip I, Godinot H, Sebban C, Salles G, Thiebaut A, Biron P, Lopez F, Mazars P, Roubi N, Leemhuis T, Hanania E, Reading C, Fine G, Atkinson K, Juttner C, Coiffier B, Fière D, Archimbaud E.

Exp Hematol. 2000 Jul;28(7):858-70.

PMID:
10907648
15.

Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.

Van Epps DE, Bender J, Lee W, Schilling M, Smith A, Smith S, Unverzagt K, Law P, Burgess J.

Blood Cells. 1994;20(2-3):411-23.

PMID:
7538347
16.
17.

Human umbilical cord blood: immunophenotypic heterogeneity of CD34+ hematopoietic progenitor cells.

D'Arena G, Musto P, Cascavilla N, Di Giorgio G, Zendoli F, Carotenuto M.

Haematologica. 1996 Sep-Oct;81(5):404-9.

18.

[CD34+ cells: biological aspects].

Benedetti F.

Tumori. 1996 Mar-Apr;82(2 Suppl):S3-13. Review. Italian.

PMID:
8928236
19.

CD34 expression on long-term repopulating hematopoietic stem cells changes during developmental stages.

Matsuoka S, Ebihara Y, Xu M, Ishii T, Sugiyama D, Yoshino H, Ueda T, Manabe A, Tanaka R, Ikeda Y, Nakahata T, Tsuji K.

Blood. 2001 Jan 15;97(2):419-25.

20.

Positive stem cell selection--basic science.

Civin CI, Strauss LC, Fackler MJ, Trischmann TM, Wiley JM, Loken MR.

Prog Clin Biol Res. 1990;333:387-401; discussion 402.

PMID:
1689854

Supplemental Content

Support Center